138 related articles for article (PubMed ID: 16299253)
1. Carbonic anhydrase II is a tumor vessel endothelium-associated antigen targeted by dendritic cell therapy.
Yoshiura K; Nakaoka T; Nishishita T; Sato K; Yamamoto A; Shimada S; Saida T; Kawakami Y; Takahashi TA; Fukuda H; Imajoh-Ohmi S; Oyaizu N; Yamashita N
Clin Cancer Res; 2005 Nov; 11(22):8201-7. PubMed ID: 16299253
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of 1D-myo-inositol 1,4,5-trisphosphate 3-kinase A protein expression in oral squamous cell carcinoma.
Kato H; Uzawa K; Onda T; Kato Y; Saito K; Nakashima D; Ogawara K; Bukawa H; Yokoe H; Tanzawa H
Int J Oncol; 2006 Apr; 28(4):873-81. PubMed ID: 16525636
[TBL] [Abstract][Full Text] [Related]
3. Dendritic cells loaded with killed allogeneic melanoma cells can induce objective clinical responses and MART-1 specific CD8+ T-cell immunity.
Palucka AK; Ueno H; Connolly J; Kerneis-Norvell F; Blanck JP; Johnston DA; Fay J; Banchereau J
J Immunother; 2006; 29(5):545-57. PubMed ID: 16971810
[TBL] [Abstract][Full Text] [Related]
4. Tumor antigens isolated from a patient with vitiligo and T-cell-infiltrated melanoma.
Kiniwa Y; Fujita T; Akada M; Ito K; Shofuda T; Suzuki Y; Yamamoto A; Saida T; Kawakami Y
Cancer Res; 2001 Nov; 61(21):7900-7. PubMed ID: 11691810
[TBL] [Abstract][Full Text] [Related]
5. Preparation of fully activated dendritic cells capable of priming tumor-specific cytotoxic T lymphocytes in patients with metastatic cancer using penicillin-killed streptococcus pyogenes (OK432) and anti-CD40 antibody.
Kontani K; Teramoto K; Ozaki Y; Sawai S; Tezuka N; Ishida H; Kajino K; Fujino S; Yamauchi A; Taguchi O; Kannagi R; Yokomise H; Ogasawara K
Oncol Rep; 2007 Apr; 17(4):895-902. PubMed ID: 17342333
[TBL] [Abstract][Full Text] [Related]
6. Immunologic and clinical effects of injecting mature peptide-loaded dendritic cells by intralymphatic and intranodal routes in metastatic melanoma patients.
Lesimple T; Neidhard EM; Vignard V; Lefeuvre C; Adamski H; Labarrière N; Carsin A; Monnier D; Collet B; Clapisson G; Birebent B; Philip I; Toujas L; Chokri M; Quillien V
Clin Cancer Res; 2006 Dec; 12(24):7380-8. PubMed ID: 17189411
[TBL] [Abstract][Full Text] [Related]
7. Expression and immunogenicity of a tumor-associated antigen, 90K/Mac-2 binding protein, in lung carcinoma.
Ozaki Y; Kontani K; Hanaoka J; Chano T; Teramoto K; Tezuka N; Sawai S; Fujino S; Yoshiki T; Okabe H; Ohkubo I
Cancer; 2002 Nov; 95(9):1954-62. PubMed ID: 12404290
[TBL] [Abstract][Full Text] [Related]
8. A study of dendritic and endothelial cell interactions in colon cancer in a cell line and small mammal model.
Yoneyama S; Okaji Y; Tsuno NH; Kawai K; Yamashita H; Tsuchiya T; Yamada J; Sunami E; Osada T; Kitayama J; Takahashi K; Nagawa H
Eur J Surg Oncol; 2007 Dec; 33(10):1191-8. PubMed ID: 17314028
[TBL] [Abstract][Full Text] [Related]
9. Identification of an inflammation-inducible serum protein recognized by anti-disialic acid antibodies as carbonic anhydrase II.
Yasukawa Z; Sato C; Kitajima K
J Biochem; 2007 Mar; 141(3):429-41. PubMed ID: 17298961
[TBL] [Abstract][Full Text] [Related]
10. Carbonic anhydrase II in the endothelium of glial tumors: a potential target for therapy.
Haapasalo J; Nordfors K; Järvelä S; Bragge H; Rantala I; Parkkila AK; Haapasalo H; Parkkila S
Neuro Oncol; 2007 Jul; 9(3):308-13. PubMed ID: 17435181
[TBL] [Abstract][Full Text] [Related]
11. Combined immunocell therapy using activated lymphocytes and monocyte-derived dendritic cells for malignant melanoma.
Goto S; Kaneko T; Miyamoto Y; Eriguchi M; Kato A; Akeyama T; Fujimoto K; Tomonaga M; Egawa K
Anticancer Res; 2005; 25(6A):3741-6. PubMed ID: 16302734
[TBL] [Abstract][Full Text] [Related]
12. Proteomics-based approach identifying autoantibody against peroxiredoxin VI as a novel serum marker in esophageal squamous cell carcinoma.
Fujita Y; Nakanishi T; Hiramatsu M; Mabuchi H; Miyamoto Y; Miyamoto A; Shimizu A; Tanigawa N
Clin Cancer Res; 2006 Nov; 12(21):6415-20. PubMed ID: 17085654
[TBL] [Abstract][Full Text] [Related]
13. Serum amyloid A mediates the inhibitory effect of Ganoderma lucidum polysaccharides on tumor cell adhesion to endothelial cells.
Li YB; Wang R; Wu HL; Li YH; Zhong LJ; Yu HM; Li XJ
Oncol Rep; 2008 Sep; 20(3):549-56. PubMed ID: 18695905
[TBL] [Abstract][Full Text] [Related]
14. Sperm-associated antigen 9, a novel cancer testis antigen, is a potential target for immunotherapy in epithelial ovarian cancer.
Garg M; Chaurasiya D; Rana R; Jagadish N; Kanojia D; Dudha N; Kamran N; Salhan S; Bhatnagar A; Suri S; Gupta A; Suri A
Clin Cancer Res; 2007 Mar; 13(5):1421-8. PubMed ID: 17332284
[TBL] [Abstract][Full Text] [Related]
15. Identification of tumor antigens that elicit a humoral immune response in breast cancer patients' sera by serological proteome analysis (SERPA).
Hamrita B; Chahed K; Kabbage M; Guillier CL; Trimeche M; Chaïeb A; Chouchane L
Clin Chim Acta; 2008 Jul; 393(2):95-102. PubMed ID: 18424265
[TBL] [Abstract][Full Text] [Related]
16. A cryptic vascular endothelial growth factor T-cell epitope: identification and characterization by mass spectrometry and T-cell assays.
Weinzierl AO; Maurer D; Altenberend F; Schneiderhan-Marra N; Klingel K; Schoor O; Wernet D; Joos T; Rammensee HG; Stevanović S
Cancer Res; 2008 Apr; 68(7):2447-54. PubMed ID: 18381453
[TBL] [Abstract][Full Text] [Related]
17. Up-regulated manganese superoxide dismutase expression increases apoptosis resistance in human esophageal squamous cell carcinomas.
Hu H; Luo ML; Du XL; Feng YB; Zhang Y; Shen XM; Xu X; Cai Y; Han YL; Wang MR
Chin Med J (Engl); 2007 Dec; 120(23):2092-8. PubMed ID: 18167182
[TBL] [Abstract][Full Text] [Related]
18. Glycoprotein nonmetastatic melanoma protein B, a potential molecular therapeutic target in patients with glioblastoma multiforme.
Kuan CT; Wakiya K; Dowell JM; Herndon JE; Reardon DA; Graner MW; Riggins GJ; Wikstrand CJ; Bigner DD
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):1970-82. PubMed ID: 16609006
[TBL] [Abstract][Full Text] [Related]
19. Growth-regulated oncogene is pivotal in thrombin-induced angiogenesis.
Caunt M; Hu L; Tang T; Brooks PC; Ibrahim S; Karpatkin S
Cancer Res; 2006 Apr; 66(8):4125-32. PubMed ID: 16618733
[TBL] [Abstract][Full Text] [Related]
20. Tumor immunotherapy targeting fibroblast activation protein, a product expressed in tumor-associated fibroblasts.
Lee J; Fassnacht M; Nair S; Boczkowski D; Gilboa E
Cancer Res; 2005 Dec; 65(23):11156-63. PubMed ID: 16322266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]